Antidote has put together a series of informational whitepapers based on surveys with patients, conversations with partners, and years of experience in patient recruitment. Download them for our guidance and perspective on engaging patients in the clinical research process.
When we understand why patients take part in research, we can make clinical trial recruitment – and every clinical research step – more effective and engaging. We partnered with Scorr Marketing to survey nearly 4,000 patients about their attitudes towards clinical trials and what motivates them to take part. We shared highlights from our findings in this executive summary.
Patients are interested in research participation: they just need to be approached in the right way. This whitepaper, the first in a series, digs into the results of our survey of ~4,000 patients and parses out how both condition area and race affect both patient willingness to take part and the types of trials patients would consider. These findings offer insights into selecting the right recruitment strategy.
Clinical trial recruitment is notoriously difficult. Even trials that meet their targets may not enroll a diverse group that reflects real-world patient populations. So how can we better engage patients from all walks of life in research? Our whitepaper explores how patients choose to participate – or not participate – in a clinical trial.
Structural barriers, challenging protocol, lack of awareness – we’re learning more and more about the reasons patients don’t participate in research. But what motivates the select few that do take part? As part of our larger survey, we asked more than 1,000 clinical trial participants about their decision to join a research study. We share those findings in this whitepaper
With increasingly complex clinical trial protocols, filling trial quotas today is more challenging than ever before, and this means that traditional methods of recruitment are becoming ineffective.
In this context, this white paper explores precision recruitment against traditional recruitment methods and demonstrates the need for this unique and tailored blend of expert digital engagement strategies, patient-specific data, and partnerships with patient communities.
In order to bring treatments that work for everyone to pharmacy shelves, clinical trials must reflect real-world populations. But unfortunately, participation rates for patients from minority groups have historically been lower than for white patients.
Nonprofits, patient advocates, and government agencies have all gotten involved in improving these statistics. But have their efforts worked?
In our report, we outline the latest progress toward true diversity in research, and what we can do next.
We’d love to hear from you